SZodixStudyAcademic Library
ShelvesOpen access
Study · an open academic library·Metadata from OpenAlex (CC0)·Shelves·OpenAlex metadata, de-duplicated
Cost‐effectiveness of expanded human immunodeficiency virus‐testing protocols for donated blood
7 references·16 citing·46 second hop
Cost‐effectiveness of expanded human immunodeficiency virus‐testing protocols for donated blood (1997)Cost‐effectiveness of expanded human immu…The Risk of Transfusion-Transmitted Viral Infections (1996)The Risk of Transfusion-Trans…Estimated Risk of Transmission of the Human Immunodeficiency Virus by Screened Blood in the United States (1995)Estimated Risk of Transmissio…Collection and transfusion of blood and blood components in the United States, 1992 (1995)Collection and transfusion of…Collection and transfusion of blood and blood components in the United States, 1989 (1993)Collection and transfusion of…Risk of human immunodeficiency virus (HIV) transmission by blood transfusions before the implementation of HIV‐1 antibody screening (1991)Risk of human immunodeficienc…The Markov Process in Medical Prognosis (1983)The Markov Process in Medical…Clinical Decision Analysis (1980)Clinical Decision AnalysisCost‐effectiveness of additional blood screening tests in the Netherlands (2011)Cost‐effectiveness of additio…A review and critique of modelling in prioritising and designing screening programmes (2007)A review and critique of mode…Surveillance of risk profiles among new and repeat blood donors with transfusion‐transmissible infections from 1995 through 2003 in the Netherlands (2006)Surveillance of risk profiles…False‐reactive microbiologic screening test results in Swedish blood donors—how big is the problem? A survey among blood centers and deferred donors (2006)False‐reactive microbiologic …Community Blood Supply Model: Development of a New Model to Assess the Safety, Sufficiency, and Cost of the Blood Supply (2005)Community Blood Supply Model:…Economic analyses of blood safety and transfusion medicine interventions: a systematic review (2004)Economic analyses of blood sa…Ensuring blood safety and availability in the US: technological advances, costs, and challenges to payment—final report (2003)Ensuring blood safety and ava…Residual risk of transfusion in Ghana (2001)Residual risk of transfusion …Long‐term survival in transfusion recipients in Sweden, 1993 (2001)Long‐term survival in transfu…Equity and the economic evaluation of healthcare (2001)Equity and the economic evalu…Preference-Based Measures in Economic Evaluation in Health Care (2000)Preference-Based Measures in …NAT and blood safety: what is the paradigm? (2000)NAT and blood safety: what is…Cost-utility analyses of clinical preventive services (2000)Cost-utility analyses of clin…Blood Screening by Nucleic Acid Amplification Technology: Current Issues, Future Challenges (2000)Blood Screening by Nucleic Ac…Transfusion‐transmitted diseases: risks, prevention and perspectives (1999)Transfusion‐transmitted disea…Direct HIV testing in blood donations: variation of the yield with detection threshold and pool size (1999)Direct HIV testing in blood d…Transmission of Human Immunodeficiency Virus (HIV) by Blood Transfusions Screened as Negative for HIV Antibody (1988)Exposure of Patients to Human Immunodeficiency Virus through the Transfusion of Blood Components That Test Antibody-Negative (1989)Transmission of Retroviruses by Transfusion of Screened Blood in Patients Undergoing Cardiac Surgery (1989)Evaluation of Screened Blood Donations for Human Immunodeficiency Virus Type 1 Infection by Culture and DNA Amplification of Pooled Cells (1991)Seroprevalence of hepatitis B, C and HIV in blood donors in northern Pakistan. (2002)Hepatitis B, hepatitis C and HIV transfusion‐transmitted infections in the 21st century (2010)Anarchy, State, and Utopia (1975)Cost-Effectiveness in Health and Medicine (1996)Quality of Systematic Reviews of Economic Evaluations in Health Care (2002)QALYs and the capability approach (2005)The use of economic evaluations in NHS decision-making: a review and empirical investigation (2008)Anarchy, State, and Utopia (2018)Intransitivity of preferences. (1969)Probabilistic Sensitivity Analysis Using Monte Carlo Simulation (1985)Utility approach to measuring health-related quality of life (1987)Utilities and Quality-Adjusted Life Years (1989)The development of a six‐item short‐form of the state scale of the Spielberger State—Trait Anxiety Inventory (STAI) (1992)Principles of Good Practice for Decision Analytic Modeling in Health-Care Evaluation: Report of the ISPOR Task Force on Good Research Practices—Modeling Studies (2003)Decision-Analytic Modeling to Evaluate Benefits and Harms of Medical Tests: Uses and Limitations (2009)Calibrating Models in Economic Evaluation (2010)Management of developmental speech and language disorders: Part 1 (2015)The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. (1992)The MOS 36-ltem Short-Form Health Survey (SF-36) (1992)A 12-Item Short-Form Health Survey (1996)Mapping the EQ-5D Index from the SF-12: US General Population Preferences in a Nationally Representative Sample (2006)Patient Perceptions of Quality of Life With Diabetes-Related Complications and Treatments (2007)Canadian Valuation of EQ-5D Health States: Preliminary Value Set and Considerations for Future Valuation Studies (2012)Collection and Transfusion of Blood in the United States, 1982–1988 (1990)The Risk of Transfusion-Transmitted Infection (1992)False-Positive HIV-1 Test Results in a Low-Risk Screening Setting of Voluntary Blood Donation (1998)Blood collection and transfusion in the United States in 2001 (2007)The United States' potential blood donor pool: estimating the prevalence of donor‐exclusion factors on the pool of potential donors (2007)XXIV. On the nature of the function expressive of the law of human mortality, and on a new mode of determining the value of life contingencies. In a letter to Francis Baily, Esq. F. R. S. &c (1825)A Population Study. (1975)A convenient approximation of life expectancy (the “DEALE”) (1982)The Beaver Dam Health Outcomes study (1993)Decision Making in Health and Medicine: Integrating Evidence and Values (2001)State-Transition Modeling: A Report of the ISPOR-SMDM Modeling Good Research Practices Task Force-3 (2012)Collection and transfusion of blood and blood components in the United States, 1994 (1998)Feasibility and efficacy of routine PCR screening of blood donations for hepatitis C virus, hepatitis B virus, and HIV-1 in a blood-bank setting (1999)Trends in Incidence and Prevalence of Major Transfusion-Transmissible Viral Infections in US Blood Donors, 1991 to 1996 (2000)Current prevalence and incidence of infectious disease markers and estimated window‐period risk in the American Red Cross blood donor population (2002)Detection of HIV-1 and HCV Infections among Antibody-Negative Blood Donors by Nucleic Acid–Amplification Testing (2004)A new strategy for estimating risks of transfusion‐transmitted viral infections based on rates of detection of recently infected donors (2005)Epidemiology of blood transfusion (1994)HIV and the blood supply: an analysis of crisis decision making. (1996)
this work references cited by second hop

References

  • 1996The Risk of Transfusion-Transmitted Viral Infections1,865 cited
  • 1980Clinical Decision Analysis1,415 cited
  • 1983The Markov Process in Medical Prognosis957 cited
  • 1995Estimated Risk of Transmission of the Human Immunodeficiency Virus by Screened Blood in the United States346 cited
  • 1995Collection and transfusion of blood and blood components in the United States, 1992213 cited
  • 1991Risk of human immunodeficiency virus (HIV) transmission by blood transfusions before the implementation of HIV‐1 antibody screening177 cited
  • 1993Collection and transfusion of blood and blood components in the United States, 1989163 cited

Cited by

  • 2000Preference-Based Measures in Economic Evaluation in Health Care295 cited
  • 2007A review and critique of modelling in prioritising and designing screening programmes184 cited
  • 2001Equity and the economic evaluation of healthcare141 cited
  • 2000Cost-utility analyses of clinical preventive services111 cited
  • 2000NAT and blood safety: what is the paradigm?68 cited
  • 2005Community Blood Supply Model: Development of a New Model to Assess the Safety, Sufficiency, and Cost of the Blood Supply59 cited
  • 1999Transfusion‐transmitted diseases: risks, prevention and perspectives57 cited

Only edges whose both ends are imported exist here. Widen the year window, or show the whole map. Back to the work

  • 2003Ensuring blood safety and availability in the US: technological advances, costs, and challenges to payment—final report55 cited
  • 2006Surveillance of risk profiles among new and repeat blood donors with transfusion‐transmissible infections from 1995 through 2003 in the Netherlands52 cited
  • 2001Residual risk of transfusion in Ghana51 cited
  • 2000Blood Screening by Nucleic Acid Amplification Technology: Current Issues, Future Challenges47 cited
  • 2001Long‐term survival in transfusion recipients in Sweden, 199343 cited
  • 1999Direct HIV testing in blood donations: variation of the yield with detection threshold and pool size37 cited
  • 2011Cost‐effectiveness of additional blood screening tests in the Netherlands35 cited
  • 2004Economic analyses of blood safety and transfusion medicine interventions: a systematic review35 cited
  • 2006False‐reactive microbiologic screening test results in Swedish blood donors—how big is the problem? A survey among blood centers and deferred donors33 cited